The rational design of lipid nanoparticles (LNPs) for targeted drug delivery represents one of the greatest challenges in modern nanomedicine. The protein corona that forms on the lipid surface after intravenous administration largely determines the biodistribution and efficacy of the nanocarrier. Traditionally, characterizing this corona requires costly mass spectrometry experiments, preventing the exploration of large lipid libraries during the design phase. In this context, artificial intelligence models such as GenShin —a graph neural network that does not require molecular poses— allow scoring lipid-protein interactions and predicting the relative composition of the corona efficiently, opening the door to massive virtual screenings. This approach combines machine learning with computational chemistry to accelerate the discovery of more selective and safer liposomal formulations.
Behind these innovations lies the development of custom applications that integrate AI models with scalable infrastructures. At Q2BSTUDIO, we apply our expertise in custom software to build platforms ranging from molecular interaction simulation to cloud workflow orchestration. The ability to process large volumes of data and train complex neural networks relies on AWS and Azure cloud services, ensuring elasticity and performance. Additionally, cybersecurity is critical when handling sensitive research data, and our pentesting protocols ensure that each system remains protected. All of this is complemented by business intelligence services and Power BI dashboards that allow scientific teams to visualize simulation and experiment results, facilitating informed decision-making.
The evolution towards autonomous AI agents capable of proposing new lipid formulations or adjusting experimental parameters in real time is already a reality. At Q2BSTUDIO, we develop AI for businesses and specialized AI agents in the biopharmaceutical domain, integrating models like GenShin into automated discovery pipelines. Our artificial intelligence approach not only accelerates research but also democratizes access to high-level predictive tools, transforming the way future nanomaterials are designed.
